A phase II trial of pyrazoloacridine (PZA) in squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. [electronic resource]
Producer: 20021004Description: 151-4 p. digitalISSN:- 0344-5704
- Acridines -- administration & dosage
- Adult
- Aged
- Carcinoma, Squamous Cell -- drug therapy
- Drug Administration Schedule
- Enzyme Inhibitors -- administration & dosage
- Female
- Humans
- Infusions, Intravenous
- Intercalating Agents -- administration & dosage
- Middle Aged
- Neutropenia -- chemically induced
- Nucleic Acid Synthesis Inhibitors -- administration & dosage
- Pyrazoles -- administration & dosage
- Remission Induction
- Salvage Therapy
- Treatment Outcome
- Uterine Cervical Neoplasms -- drug therapy
- Vomiting -- chemically induced
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.